Results 141 to 150 of about 6,778,204 (293)

Time, the final frontier

open access: yesMolecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain   +3 more
wiley   +1 more source

Emergent Endovascular Intervention for Acute Neurological Deficits Post-Carotid Endarterectomy: A Single-Institutional Analysis and Systematic Review of the Literature. [PDF]

open access: yesJ Neuroendovasc Ther
Porto CM   +10 more
europepmc   +1 more source

100 Books for 100 Years

open access: yesPapers of The Bibliographical Society of Canada, 2002
openaire   +2 more sources

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

MTAP immunohistochemistry as a surrogate marker of CDKN2A loss in brain tumors: A meta-analysis and literature review. [PDF]

open access: yesJ Neuropathol Exp Neurol
Dono A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy